ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00050141
Recruitment Status : Completed
First Posted : November 28, 2002
Last Update Posted : February 1, 2013
Sponsor:
Information provided by (Responsible Party):
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.